|
Jan 30
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
|
Jan 28
|
FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication
|
|
Jan 27
|
Is BioMarin Pharmaceutical (BMRN) the Best Depressed Stock to Invest in Now?
|
|
Jan 27
|
BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?
|
|
Jan 27
|
NVO Stock Rises as New Obesity Drug Shows Superior Weight Loss
|
|
Jan 27
|
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
|
|
Jan 3
|
10 Magnificent Stocks That Can Make You Richer in 2025
|
|
Jan 2
|
BMRN or TECH: Which Is the Better Value Stock Right Now?
|
|
Oct 1
|
3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)
|
|
Oct 1
|
BMRN or MYGN: Which Is the Better Value Stock Right Now?
|
|
Oct 1
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
Oct 1
|
Down -22.94% in 4 Weeks, Here's Why You Should You Buy the Dip in BioMarin (BMRN)
|
|
Sep 30
|
Andreas Halvorsen's Firm Expands Grip in BioMarin Pharmaceutical Inc Holding
|
|
Sep 30
|
Andreas Halvorsen's Strategic Acquisition in BioMarin Pharmaceutical Inc
|
|
Sep 30
|
High Growth Tech Stocks To Watch For Future Potential
|
|
Sep 25
|
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
|
|
Sep 8
|
BioMarin Pharmaceutical Inc. (BMRN): Is This Biotech Stock A Good Buy?
|
|
Sep 5
|
BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years
|
|
Sep 4
|
BioMarin, having retrenched, outlines plans for growth
|
|
Sep 4
|
BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial Guidance
|